DR. REDDY'S LABORATORIES-ADR (RDY) Stock Income Statement
NYSE:RDY - New York Stock Exchange, Inc. - US2561352038 - ADR - Currency: USD
| TTM (2024-12-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 312.29B | 280.11B | 246.70B | 215.45B | 190.47B | |||
| Minority Interest Expense | -767.00M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 92.22B | 89.40B | 83.05B | 79.97B | 65.65B | |||
| Gross Profit | 220.07B | 190.71B | 163.65B | 135.48B | 124.83B | |||
| Operating Expenses | 152.37B | 126.08B | 110.75B | 100.15B | 91.61B | |||
| Research and Development | N/A | 19.35B | 16.20B | 15.10B | 15.47B | |||
| Selling, General, and Administrative Expenses | 136.20B | 92.03B | 82.05B | 73.40B | 63.85B | |||
| Operating Income | 67.71B | 64.63B | 52.90B | 35.33B | 33.22B | |||
| Interest Income/Expense | -2.57B | 4.14B | 3.21B | 2.81B | 2.00B | |||
| Other Income/Expense | 8.41B | 2.34B | 6.29B | 657.00M | 421.00M | |||
| Non Recurring Items | -752.00M | -3.00M | -699.00M | -9.30B | -6.77B | |||
| Income Before Taxes | 72.80B | 72.01B | 60.48B | 30.61B | 28.84B | |||
| Income Tax | 18.31B | 16.23B | 15.41B | 8.83B | 9.63B | |||
| Net Income | 53.72B | 55.78B | 45.07B | 21.82B | 19.52B | |||
| EBITDA | N/A | 79.33B | 65.40B | 46.98B | 45.51B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 64.52 | 67.03 | 54.27 | 26.28 | 117.76 | |||
| Non GAAP EPS | 64.47 | 67.00 | 54.27 | 28.51 | 23.07 | |||
| Statistics | ||||||||
| Gross Profit Margin | 70.47% | 68.08% | 66.34% | 62.88% | 65.54% | |||
| Profit Margin | 17.20% | 19.91% | 18.27% | 10.13% | 10.25% | |||
| Operating Profit Margin | 21.68% | 23.07% | 21.44% | 16.40% | 17.44% | |||
All data in INR